Skip Navigation

Find a Doctor

Find a Researcher

Researchers

Chiadi Onyike, M.B.B.S., M.D.

Chiadikaobi Uchendu Onyike, M.B.B.S., M.D.

Photo of Dr. Chiadi Onyike, M.B.B.S., M.D.
  • Director, Frontotemporal Dementias Program
  • Associate Professor of Psychiatry and Behavioral Sciences
Male

Languages: English, Igbo

Expertise

Adult Psychiatry, Alzheimer's Disease (AD), Behavioral Disorders in Dementia, Behavioral Medicine, Cognitive Disorders , Creutzfeldt-Jakob Disease, Dementia, Disorders of Executive Function, Disorders of Social Cognition, Frontotemporal Dementias, Geriatric Psychiatry, Neuropsychiatry, Primary Aphasias, Prion Diseases, Psychiatry, Psychiatry and Behavioral Sciences, Young-Onset Dementias ...read more

Research Interests

Phenomenology; neuropsychiatry; neuropathology; epidemiology; measurement and management of neurodegenerative disorders (including frontotemporal dementias, young-onset Alzheimer disease, Lewy body disease and other parkinsonian dementias, cerebrovascular dementias, prion disease, leukodystrophies); treatment development and clinical trials for neurodegenerative disease ...read more

Request an Appointment

Insurance Information

Maryland

410-955-5147
Request Appointment

Outside of Maryland

410-464-6641
Request Appointment

International Patients

+1-410-502-7683
Request Appointment

Locations

The Johns Hopkins Hospital

Appointment Phone: 410-955-5147
600 N. Wolfe Street
Meyer Building, Suite 235
Baltimore, MD 21287 map
Phone: 410-955-5147 | Fax: 410-502-4133

Background

Dr. Onyike is specialized in neuropsychiatry and focuses on the care of individuals who have neurodegenerative dementias. His practice focuses on conditions that develop in midlife or earlier, including frontotemporal dementias, young-onset Alzheimer diseases, prion diseases, leukodystrophy and other atypical conditions that cause cognitive and behavioral impairments and dementia. He is principal investigator or co-investigator of studies focused on the epidemiology and treatment of the frontotemporal dementias, Alzheimer disease, Lewy body disease, spinocerebellar ataxias, and other neurodegenerative disorders.

Dr. Onyike is a member of the Medical Advisory Council of the Association for Frontotemporal Degeneration, the FTD Disorders Registry Scientific Advisory Board and the FDA Advisory Committee for Central and Peripheral Nervous System Drugs. He serves on the Alzheimer’s Association Best Clinical Practices Guidelines Work Group, and has participated in NIA/NINDS Alzheimer’s Disease and Related Dementias workshop committees. He is a founding member of the International Society for Frontotemporal Dementias.

...read more

Titles

  • Director, Frontotemporal Dementias Program
  • Director, Young-Onset Dementias Program
  • Co-Director, Lewy Body Disease Research Center of Excellence
  • Associate Professor of Psychiatry and Behavioral Sciences

Departments / Divisions

Centers & Institutes

Education

Degrees

  • MD, College of Medicine (1991)

Residencies

  • Johns Hopkins University School of Medicine / Psychiatry (2000)

Fellowships

  • Johns Hopkins University School of Medicine (2002)

Research & Publications

Clinical Trial Keywords

Alzheimer's, frontotemporal dementia, clinical trial

Selected Publications

View all on Pubmed

Kamath V, Chaney GS, DeRight J, Onyike CU. A meta-analysis of neuropsychological, social cognitive, and olfactory functioning in the behavioral and language variants of frontotemporal dementia. Psychol Med. 2018 Dec 6;:1-12. doi: 10.1017/S0033291718003604. PubMed PMID: 30520407

Tsapkini K, Webster KT, Ficek BN, Desmond JE, Onyike CU, Rapp B, Frangakis CE, Hillis AE. Electrical brain stimulation in different variants of primary progressive aphasia: A randomized clinical trial. Alzheimers Dement (N Y). 2018;4:461-472. doi: 10.1016/j.trci.2018.08.002. eCollection 2018. PubMed PMID: 30258975; PubMed Central PMCID: PMC6153381

Ismail Z, Agüera-Ortiz L, Brodaty H, Cieslak A, Cummings J, Fischer CE, Gauthier S, Geda YE, Herrmann N, Kanji J, Lanctôt KL, Miller DS, Mortby ME, Onyike CU, Rosenberg PB, Smith EE, Smith GS, Sultzer DL, Lyketsos C. The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre-Dementia Populations. J Alzheimers Dis. 2017;56(3):929-938. doi: 10.3233/JAD-160979. PubMed PMID: 28059789; PubMed Central PMCID: PMC5652315

Kansal K, Yang Z, Fishman AM, Sair HI, Ying SH, Jedynak BM, Prince JL, Onyike CU. Structural cerebellar correlates of cognitive and motor dysfunctions in cerebellar degeneration. Brain. 2017 Mar 1;140(3):707-720. doi: 10.1093/brain/aww327. PubMed PMID: 28043955; PubMed Central PMCID: PMC5837314

Kansal K, Mareddy M, Sloane KL, Minc AA, Rabins PV, McGready JB, Onyike CU. Survival in Frontotemporal Dementia Phenotypes: A Meta-Analysis. Dement Geriatr Cogn Disord. 2016;41(1-2):109-22. doi: 10.1159/000443205. Epub 2016 Feb 9. Review. PubMed PMID: 26854827

Activities & Honors

Honors

  • Board of Directors, Alzheimers Association of Greater Maryland
  • Medical and Scientific Advisory Board, Alzheimers Association of Greater Maryland
  • World Federation of Neurology Research Group on Aphasia and Cognitive Disorders
  • Medical Advisory Committee, Association for Frontotemporal Degeneration
  • Finance Committee, International Society for Frontotemporal Dementias
  • Peripheral and Central Nervous Systems Drugs Advisory Committee, US Food and Drug Administration

Memberships

  • American Association for Geriatric Psychiatry
  • American Neuropsychiatric Association
  • American Psychiatric Association
  • International Psychogeriatric Society
  • International Society for Frontotemporal Dementias
  • International Society to Advance Alzheimer Research and Treatment (ISTAART)
  • Maryland Psychiatric Society
  • Society for Behavioral and Cognitive Neurology
  • Association of Nigerian Physicians in the Americas

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 

Comments

Loading...
Is this you? Edit Profile
back to top button